2021
DOI: 10.1016/j.carrev.2020.09.029
|View full text |Cite
|
Sign up to set email alerts
|

Outcomes After Coronary Orbital Atherectomy at Centers Without On-Site Surgical Backup: Diabetics Versus Non-Diabetics and Impact of Access Site

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(9 citation statements)
references
References 25 publications
0
8
0
1
Order By: Relevance
“…While CTO interventions have been associated with higher risk for dissection and emergency surgery, 12,13 retrospective studies report reasonably low complication rates including 4% perforation, 1% tamponade, 1.4% death, 1.1% MI, 1.8% target lesion revascularization, and 1.1% CVA 14,15 . Similarly, retrospective analyses of orbital and rotational atherectomy in no‐SOS centers have acceptable outcomes with 30‐day MACE of 1.4% with orbital atherectomy and overall complication rate of less than 6% with rotational atherectomy 16,17 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…While CTO interventions have been associated with higher risk for dissection and emergency surgery, 12,13 retrospective studies report reasonably low complication rates including 4% perforation, 1% tamponade, 1.4% death, 1.1% MI, 1.8% target lesion revascularization, and 1.1% CVA 14,15 . Similarly, retrospective analyses of orbital and rotational atherectomy in no‐SOS centers have acceptable outcomes with 30‐day MACE of 1.4% with orbital atherectomy and overall complication rate of less than 6% with rotational atherectomy 16,17 …”
Section: Discussionmentioning
confidence: 99%
“…14,15 Similarly, retrospective analyses of orbital and rotational atherectomy in no-SOS centers have acceptable outcomes with 30-day MACE of 1.4% with orbital atherectomy and overall complication rate of less than 6% with rotational atherectomy. 16,17 While no-SOS centers perform the minority of PCI cases in the US, many PCIs are done at no-SOS centers internationally and even represent the majority in some countries. 10 Given the above outcomes data and the historical practice variation between the US and international sites, it is unsurprising that our survey found that international operators were much more comfortable in performing PCI on left main lesions, 3-vessel disease, the last remaining conduit, lesions that jeopardize a large amount of myocardial territory, lesions with greater than moderate calcification, and the use atherectomy, cutting balloon, or laser devices.…”
Section: No-sos Operators: Us Versus International Procedural Prefere...mentioning
confidence: 99%
“…A retrospective analysis of 221 cases using orbital atherectomy at no-SOS sites reported an in-hospital MACE rate of 0.5% (1 MI) and 30-day MACE rate of 1.4%. 39 In-hospital coronary perforation and no reflow were reported at 0.5% and procedural success was 97.3%. A retrospective analysis of 531 patients undergoing rotational atherectomy (RA) in 3 no-SOS centers in Australia noted 11 (2.1%) procedure-related deaths (of which 5 were directly attributable to RA) within 30 days.…”
Section: Pci Of Complex Lesions In No-sos Centersmentioning
confidence: 95%
“…Although OA is not approved for in-stent restenosis (ISR), a small study (41 patients) reported technical success of 98%, a MACCE rate of 5% (2 patients) driven solely by procedural MI, severe no reflow in 5% and no perforations requiring interventional therapy, highlighting that OA has a reasonably good safety profile for atherectomy in ISR [24]. OA has also been shown to be safe for use without on-site cardiovascular surgical services, with a low rate of perforation (0.5%), flow-limiting dissection (0.5%), MACE (1.4%) and cardiac death (0.5%) [25], comparable to a multicenter registry report demonstrating an emergency CABG rate of 0.2% [21]. Currently, according to the manufacturer's Instructions for Use (IFU), OA is contraindicated in lesions within a bypass graft or stent, with the presence of thrombus, in the last remaining coronary artery or if there is evidence of coronary dissection [26].…”
Section: Orbital Atherectomymentioning
confidence: 98%